Skip to main content
All lobbying filings

WESTMORELAND160, LLC

WESTMORELAND160, LLC filed a Q3 report for Phlow Corporation on October 17, 2026, reporting $45,000 in lobbying income.

Lobbying for Phlow Corporation · Pharmaceutical manufacturer

As filed: WESTMORELAND160, LLC for PHLOW CORPORATION.

All filings by WESTMORELAND160, LLC · Everything Phlow Corporation has reported

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 17, 2026
Income
$45,000
What the client paid this registrant for the period.
Client based in
Virginia

Official filing document

 Lobbyists on this filing 1
  • WILLIAM THOMAS RICE
    Previously held: Senior Policy Advisor, Rep. David Price Military Legislative Assistant, Rep. Bud Cramer Legislative Director, Rep. Henry Bonilla Military Legislative Assistant/ Appropriations Associate, Rep. Bill Young

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2
Budget/Appropriations

Department of Defense Appropriations Act, 2027 (H.R.9495; S.XXXX) (Provisions related to domestic supply chain for pharmaceuticals and Military health and Threat Reduction) Fiscal Year 2027 National Defense Authorization Act (H.R.8800; S.4784) (Provisions related to domestic supply chain for pharmaceuticals and Military health and Threat Reduction) FY2027 Continuing Appropriations and Extensions Act (H.R. 6500)

Defense

Department of Defense Appropriations Act, 2027 (H.R.9495; S.XXXX) (Provisions related to domestic supply chain for pharmaceuticals and Military health and Threat Reduction) Fiscal Year 2027 National Defense Authorization Act (H.R.8800; S.4784) (Provisions related to domestic supply chain for pharmaceuticals and Military health and Threat Reduction) FY2027 Continuing Appropriations and Extensions Act (H.R. 6500)

 Bills named in this filing 4
  • H.R. 9495
    Department of Defense Appropriations Act, 2027
  • H.R. 8800
    National Defense Authorization Act for Fiscal Year 2027
  • S. 4784
    National Defense Authorization Act for Fiscal Year 2027
  • H.R. 6500
    Continuing Appropriations and Extensions Act, 2027

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem